(Q24595527)
Statements
A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers (English)
0 references
May 2011
0 references
10
0 references
742-51
0 references
5
0 references
1 reference
1 reference